Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2014

Main Data: 31/12 Year 2014
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 854.61
– gross industrial income 358.20
– total operating cost 250.29
– operating profit 107.91
– net financial expenses 18.51
– profit attributable to equity holders of the parents 51.56

 

Consolidated balance sheet Millions/Euro
– working capital – 22.59
– non-current assets 264.43
– provision for severance indemnities and other provisions – 6.79
– net debt – 118.44
– equity pertaining to the group and minority interests 116.62

 

Other information Millions/Euro
– depreciation, amortization and impairment 23.70
– R & D costs 36.22

 

  Euro
Dividend per share 1.25

 

  No.
Employees 3,730

 

  Euro
Share capital 19,150,560

 

Main Data: 30/06 Year 2014 
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 374.2
– gross industrial income 157.1
– total operating cost 124.6
– operating profit 32.5
– net financial expenses 5.2
– profit attributable to equity holders of the parents 16.0

 

Consolidated balance sheet Millions/Euro
– working capital 35.4
– non-current assets 257.3
– provision for severance indemnities and other provisions – 10.3
– net debt – 206.3
– equity pertaining to the group and minority interests 76.1

 

Other information Millions/Euro
– depreciation, amortization and impairment 10.9
– R & D costs 18.9

 

  No.
Employees 3,712

 

  Euro
Share capital 19,150,560

 

Net Sales by Sector: Year 2014
  Millions/Euro  
tea, food & other 302.67 35.4%
pharmaceutical 453.38 53.1%
ilapak 98.56 11.5%
Total 854.61 100.0%

 

Net Sales by Country: Year 2014
  Millions/Euro  
E.U. (excluding Italy) 241.99 28.3%
Other European countries 84.93 9.9%
North America 133.80 15.7%
Asia & Middle East 199.30 23.3%
Other countries 117.06 13.7%
Total exports 777.11 90.9%
Italy 77.50 9.1%
Total 854.61 100.0%